
    
      All patients were informed in detailed regarding the risk and complications and given written
      and informed consent, coming to our clinics were assessed by one of the senior team members
      of the spine, patient fulfilling the eligibility criteria were selected and included in the
      study. One week before the surgery the patients who met the eligibility criteria were
      randomized in a double-blind manner (participant and investigator) in a ratio of 1:1 into
      Group-A (Pregabalin 7mg, twice daily) or Group-B (Placebo, twice daily). The pain scores were
      recorded by VAS and Roland Morris score system on preoperative day compared to the scores on
      the 1st week postoperative follow-up.
    
  